The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Lung Cancer 101: A Complete Guide to Risks, Symptoms, Diagnosis, and Treatment
By Dr. Lei Deng
A comprehensive introduction to lung cancer covering symptoms, risk factors, screening guidelines, disparities, and modern treatment options for NSCLC and SCLC.
Lung Cancer 101: A Complete Guide to Risks, Symptoms, Diagnosis, and Treatment
By Dr. Lei Deng
A comprehensive introduction to lung cancer covering symptoms, risk factors, screening guidelines, disparities, and modern treatment options for NSCLC and SCLC.
Lung Cancer 101: A Complete Guide to Risks, Symptoms, Diagnosis, and Treatment
By Dr. Lei Deng
A comprehensive introduction to lung cancer covering symptoms, risk factors, screening guidelines, disparities, and modern treatment options for NSCLC and SCLC.
Does Sugar Feed Cancer?
By The Cancer News Team
A clear, science-based explainer on how sugar intake, insulin resistance, and inflammation influence cancer risk, progression, and treatment outcomes.
Does Sugar Feed Cancer?
By The Cancer News Team
A clear, science-based explainer on how sugar intake, insulin resistance, and inflammation influence cancer risk, progression, and treatment outcomes.
Does Sugar Feed Cancer?
By The Cancer News Team
A clear, science-based explainer on how sugar intake, insulin resistance, and inflammation influence cancer risk, progression, and treatment outcomes.
5 Early Signs and Symptoms of Stomach Cancer You Shouldn’t Ignore
By The Cancer News Team
Learn the early signs and symptoms of stomach cancer, expert insights, and key risk factors to help support early detection and better outcomes.
5 Early Signs and Symptoms of Stomach Cancer You Shouldn’t Ignore
By The Cancer News Team
Learn the early signs and symptoms of stomach cancer, expert insights, and key risk factors to help support early detection and better outcomes.
5 Early Signs and Symptoms of Stomach Cancer You Shouldn’t Ignore
By The Cancer News Team
Learn the early signs and symptoms of stomach cancer, expert insights, and key risk factors to help support early detection and better outcomes.
What Lung Cancer Doctors Want You to Know in 2025
By The Cancer News Team
Latest insights from leading thoracic oncologists on lung cancer advances in 2025, including targeted therapy, immunotherapy, early detection, and precision oncology breakthroughs.
What Lung Cancer Doctors Want You to Know in 2025
By The Cancer News Team
Latest insights from leading thoracic oncologists on lung cancer advances in 2025, including targeted therapy, immunotherapy, early detection, and precision oncology breakthroughs.
What Lung Cancer Doctors Want You to Know in 2025
By The Cancer News Team
Latest insights from leading thoracic oncologists on lung cancer advances in 2025, including targeted therapy, immunotherapy, early detection, and precision oncology breakthroughs.
Understanding PALB2 Mutations in Pancreatic Cancer
By Jonathan W Lee, MD, MSc
November marks Pancreatic Cancer Awareness Month, a time to shine a light on one of oncology's most challenging diseases.
Understanding PALB2 Mutations in Pancreatic Cancer
By Jonathan W Lee, MD, MSc
November marks Pancreatic Cancer Awareness Month, a time to shine a light on one of oncology's most challenging diseases.
Understanding PALB2 Mutations in Pancreatic Cancer
By Jonathan W Lee, MD, MSc
November marks Pancreatic Cancer Awareness Month, a time to shine a light on one of oncology's most challenging diseases.
Top 8 Takeaways on mRNA Cancer Vaccines and Personalized Immunotherapy Development
By The Cancer News Team
A comprehensive summary of key insights on mRNA cancer vaccines and personalized immunotherapy development presented at the 5th Binaytara Precision Oncology Summit.
Top 8 Takeaways on mRNA Cancer Vaccines and Personalized Immunotherapy Development
By The Cancer News Team
A comprehensive summary of key insights on mRNA cancer vaccines and personalized immunotherapy development presented at the 5th Binaytara Precision Oncology Summit.
Top 8 Takeaways on mRNA Cancer Vaccines and Personalized Immunotherapy Development
By The Cancer News Team
A comprehensive summary of key insights on mRNA cancer vaccines and personalized immunotherapy development presented at the 5th Binaytara Precision Oncology Summit.
The Future of Precision Oncology: Biomarkers and Drug Development
By The Cancer News Team
A comprehensive overview of emerging precision oncology innovations, focusing on biomarkers, drug development challenges, and the future of targeted cancer therapies.
The Future of Precision Oncology: Biomarkers and Drug Development
By The Cancer News Team
A comprehensive overview of emerging precision oncology innovations, focusing on biomarkers, drug development challenges, and the future of targeted cancer therapies.
The Future of Precision Oncology: Biomarkers and Drug Development
By The Cancer News Team
A comprehensive overview of emerging precision oncology innovations, focusing on biomarkers, drug development challenges, and the future of targeted cancer therapies.
Molecular Tumor Board 2: Interesting and Challenging Cases in Precision Oncology
By The Cancer News Team
This article summarizes the transcript from Session 11 of the 5th Binaytara Precision Oncology Summit
Molecular Tumor Board 2: Interesting and Challenging Cases in Precision Oncology
By The Cancer News Team
This article summarizes the transcript from Session 11 of the 5th Binaytara Precision Oncology Summit
Molecular Tumor Board 2: Interesting and Challenging Cases in Precision Oncology
By The Cancer News Team
This article summarizes the transcript from Session 11 of the 5th Binaytara Precision Oncology Summit
$40 Test Could Save Lives: Researcher Cracks Code on Aggressive Leukemia Affecting One-Third of Asian Patients
By The Cancer News Team
Dr. Dikshat Gupta’s $40 diagnostic test for Ph-like ALL offers a groundbreaking, affordable solution to detect aggressive leukemia subtypes common in Asian populations, advancing equitable cancer care.
$40 Test Could Save Lives: Researcher Cracks Code on Aggressive Leukemia Affecting One-Third of Asian Patients
By The Cancer News Team
Dr. Dikshat Gupta’s $40 diagnostic test for Ph-like ALL offers a groundbreaking, affordable solution to detect aggressive leukemia subtypes common in Asian populations, advancing equitable cancer care.
$40 Test Could Save Lives: Researcher Cracks Code on Aggressive Leukemia Affecting One-Third of Asian Patients
By The Cancer News Team
Dr. Dikshat Gupta’s $40 diagnostic test for Ph-like ALL offers a groundbreaking, affordable solution to detect aggressive leukemia subtypes common in Asian populations, advancing equitable cancer care.
More Treats, Fewer Tricks: Taming the Terror of Metastatic Cancer
By Dr. Binay Shah
Dr. Binay Shah explains the science of metastatic cancer, the “seed and soil” hypothesis, and how new therapies are transforming this once-terminal disease into one filled with hope.
More Treats, Fewer Tricks: Taming the Terror of Metastatic Cancer
By Dr. Binay Shah
Dr. Binay Shah explains the science of metastatic cancer, the “seed and soil” hypothesis, and how new therapies are transforming this once-terminal disease into one filled with hope.
More Treats, Fewer Tricks: Taming the Terror of Metastatic Cancer
By Dr. Binay Shah
Dr. Binay Shah explains the science of metastatic cancer, the “seed and soil” hypothesis, and how new therapies are transforming this once-terminal disease into one filled with hope.